A preprint, an unpublished non-peer reviewed study, looks at incidence of Cerebral Venous Thrombosis (CVT) after COVID-19, compared to incidence … read more
We now know that Cerebral venous thrombosis (CVT) has been reported to occur in about 5 in a million people … read more
A comment from Professor Sheila Bird on data from the UK vaccine roll-out in case useful. Prof Sheila Bird, … read more
A preprint, an unpublished non-peer reviewed study, looks at antibody generation and cellular immune responses in people over the age … read more
The Office for National Statistics (ONS) have released the latest report from the COVID-19 infection survey, looking at antibody and vaccination … read more
A new preprint from the UK Coronavirus Immunology Consortium and the University of Birmingham looks at the antibody and cellular … read more
Yesterday we hosted a briefing for science and health journalists on the extension to the COMCOV trial; a trial to … read more
The Centres for Disease Control and Prevention (CDC) and US Food & Drug Administration (FDA) have released a joint statement … read more
Meeting highlights from the European Medicines Agency’s (EMA) safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC), have been published, including … read more
We gathered two vaccine safety experts and one thrombosis/haematology expert to sit on a panel and answer journalists’ questions about … read more
Medicines regulatory bodies in the UK and Europe, the Medicines and Health products Regulatory Agency (MHRA) and European Medicines Agency … read more
Valneva have published a press release reporting positive phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. … read more
Several reports mention comments made by the European Medicines Agency’s head of vaccine strategy, Marco Cavaleri, who told an Italian … read more
The latest weekly summary of Yellow Card reporting has been published by the Medicines & Healthcare products Regulatory Agency (MHRA), … read more
Pfizer have published a press release stating that updated analysis of their Phase 3 study confirms high efficacy and no … read more
A new preprint on a University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium looks at the T-cell … read more
Pfizer have published a press release announcing positive topline results of their phase 3 trial of the Pfizer-BioNTech COVID-19 vaccine … read more
It has been reported that parts Germany have suspended the use of the Oxford-AstraZeneca in people below the age of … read more
A preprint, an unpublished non-peer reviewed study, posted on Research Square looks at the clinical and laboratory features of 9 … read more
The Office for National Statistics (ONS) have released data on the the first dose COVID-19 vaccination rates among people aged … read more
